Sandler Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Sandler Capital Management's MRK Position: Q1 2026 in Review
Sandler Capital Management sold out of Merck (MRK) in Q1 2026, closing a stake of 27,900 shares — an estimated $2.94M sold.
Sandler Capital Management first reported a position in MRK in Q4 2018 and held it in 9 quarters. The position peaked at $2.94M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Sandler Capital Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
- Sandler Capital Management sold 27,900 Merck shares in Q1 2026, an estimated $2.94M.
- Sandler Capital Management first reported a position in Merck in Q4 2018 and held it in 9 quarters.
- Sandler Capital Management's Merck position peaked at $2.94M in Q4 2025.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Sandler Capital Management's 13F filing for Q1 2026, filed 15 May 2026.